Pathophysiology of the no-reflow phenomenon

References

• van 't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle myocardial infarction study group. Lancet 1997; 350: 615–9
   PubMed Web of Science ®Google Scholar
• Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 1999; 99: 1972–7
   PubMed Web of Science ®Google Scholar
• van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle myocardial infarction study group. Circulation 1998; 97: 2302–6
   PubMed Web of Science ®Google Scholar
• Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 2002; 39: 591–7
   PubMed Web of Science ®Google Scholar
• Kloner RA, Ganote CE, Jennings RB. The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974; 54: 1496–508
   PubMed Web of Science ®Google Scholar
• Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223–8
   PubMed Web of Science ®Google Scholar
• Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109: 1121–6
   PubMed Web of Science ®Google Scholar
• Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first?. Circulation 1980; 62: 945–52
   PubMed Web of Science ®Google Scholar
• Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989; 80: 1846–61
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Kloner RA. Microvascular reperfusion injury: Rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002; 283: H1099–107
   PubMed Web of Science ®Google Scholar
• Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischaemia and reperfusion in the dog. Am J Pathol. 1983; 111: 98–111
   PubMed Web of Science ®Google Scholar
• Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword?. J Clin Invest. 1985; 76: 1713–9
   PubMed Web of Science ®Google Scholar
• Garcia-Dorado D, Piper HM. Postconditioning: Reperfusion of ‘reperfusion injury’ after hibernation. Cardiovasc Res. 2006; 69: 1–3
   Google Scholar
• Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285: H579–88
   PubMed Web of Science ®Google Scholar
• Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation 2005; 112: 2143–8
   PubMed Web of Science ®Google Scholar
• Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, et al. Long-term benefit of postconditioning. Circulation 2008; 117: 1037–44
   PubMed Web of Science ®Google Scholar
• Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischaemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 2005; 100: 179–90
   PubMed Web of Science ®Google Scholar
• Monassier J.-P. Reperfusion injury in acute myocardial infarction: From bench to cath lab. Part II: Clinical issues and therapeutic options. Arch Cardiovasc Dis. 2008; 101: 565–75
   PubMed Web of Science ®Google Scholar
• Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987; 84: 1404–7
   PubMed Web of Science ®Google Scholar
• Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: Ischaemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol. 2001; 33: 1065–89
   PubMed Web of Science ®Google Scholar
• Jezek P, Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem & Cell Biol. 2005; 37: 2478–503
   PubMed Web of Science ®Google Scholar
• Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006; 70: 181–90
   PubMed Web of Science ®Google Scholar
• VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 1987; 79: 265–74
   PubMedGoogle Scholar
• Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischaemia. FASEB J. 1991; 5: 2029–34
   PubMed Web of Science ®Google Scholar
• Vrints CJ, Bult H, Bosmans J, Herman AG, Snoeck JP. Paradoxical vasoconstriction as result of acetylcholine and serotonin in diseased human coronary arteries. Eur Heart J. 1992; 13: 824–31
   Google Scholar
• Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, et al. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J. 2008; 29: 1843–50
   PubMed Web of Science ®Google Scholar
• Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 2007; 113: 47–63
   Google Scholar
• Vasquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BSS, Karoui H, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 1998; 95: 9220–5
   PubMed Web of Science ®Google Scholar
• Wever RMF, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108–12
   PubMed Web of Science ®Google Scholar
• Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004; 24: 413–20
   PubMed Web of Science ®Google Scholar
• Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708–14
   PubMed Web of Science ®Google Scholar
• Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, Wolin MS, et al. High-dose folic acid pretreatment blunts cardiac dysfunction during ischaemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 2008; 117: 1810–9
   PubMed Web of Science ®Google Scholar
• Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004; 61: 481–97
   PubMed Web of Science ®Google Scholar
• Piper HM, Garcna-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998; 38: 291–300
   PubMed Web of Science ®Google Scholar
• Ladilov Y, Efe Ö, Schäfer C, Rother B, Kasseckert S, Abdallah Y, et al. Reoxygenation-induced rigor-type contracture. J Mol Cell Cardiol. 2003; 35: 1481–90
   Google Scholar
• Piper HM, Kasseckert S, Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res. 2006; 70: 170–3
   PubMedGoogle Scholar
• Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res. 2002; 55: 534–43
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003; 35: 339–41
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res. 2004; 61: 372–85
   PubMed Web of Science ®Google Scholar
• Halestrap AP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans. 2006; 34: 232–7
   PubMed Web of Science ®Google Scholar
• Halestrap, AP. What is the mitochondrial permeability transition pore?. J Mol Cell Cardiol. in press.
   Google Scholar
• Halestrap, AP, Pasdois, P. The role of the mitochondrial permeability transition pore in heart disease. Biochimica et Biophysica Acta (BBA)—Bioenergetics. in press.
   Google Scholar
• Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008; 359: 473–81
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Nakamura M, Wang NP, Velez DA, Hewan-Lowe KO, Guyton RA, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res. 2000; 94: 133–44
   Google Scholar
• Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570–80
   PubMed Web of Science ®Google Scholar
• Henriques JPS, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AWJ, Hoorntje JCA, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 2002; 23: 1112–7
   PubMed Web of Science ®Google Scholar
• Fokkema, ML, Vlaar, PJ, Svilaas, T, Vogelzang, M, Amo, D, Diercks, GF, , et al. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J. 2009;.
   Google Scholar
• Saber, RS , Edwards, WD , Bailey, KR , McGovern, TW , Schwartz, RS , Holmes, DR,Jr. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J Am Coll Cardiol. 1993;22:1283–8.
   PubMed Web of Science ®Google Scholar
• Okamura A, Ito H, Iwakura K, Kurotobi T, Koyama Y, Date M, et al. Clinical implications of distal embolization during coronary interventional procedures in patients with acute myocardial infarction: Quantitative study with doppler guidewire. J Am Coll Cardiol Interv. 2008; 1: 268–76
   Google Scholar
• Kawaguchi R, Oshima S, Jingu M, Tsurugaya H, Toyama T, Hoshizaki H, et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007; 50: 1641–6
   PubMed Web of Science ®Google Scholar
• De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann F.-J, Chiariello M. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: A meta-analysis of randomized trials. Am Heart J. 2007; 153: 343–53
   Google Scholar
• Burzotta F, Testa L, Giannico F, Biondi-Zoccai GGL, Trani C, Romagnoli E, et al. Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials. Int J Cardiol. 2008; 123: 313–21
   PubMed Web of Science ®Google Scholar
• Svilaas T, Vlaar PJ, van der Horst IC, Diercks GFH, de Smet BJGL, van den Heuvel AFM, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008; 358: 557–67
   PubMed Web of Science ®Google Scholar
• Vlaar PJ, Svilaas T, van der Horst IC, Diercks GFH, Fokkema ML, de Smet BJGL, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS): A 1-year follow-up study. Lancet 2008; 371: 1915–20
   PubMed Web of Science ®Google Scholar
• Burzotta F, Crea F. Thrombus-aspiration: A victory in the war against no reflow. Lancet 2008; 371: 1889–90
   Google Scholar
• Abbate A, Kontos MC, Biondi-Zoccai GGL. No-reflow: The next challenge in treatment of ST-elevation acute myocardial infarction. Eur Heart J. 2008; 29: 1795–7
   PubMed Web of Science ®Google Scholar
• Steg PG, Ducrocq G. Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: The good, the bad and the ugly. Eur Heart J. 2008; 29: 2953–4
   Google Scholar
• Yellon DM, Hausenloy DJ. Realizing the clinical potential of ischemic preconditioning and postconditioning. Nat Clin Pract Cardiovasc Med. 2005; 2: 568–75
   PubMedGoogle Scholar